Faruk Uguz1, Mine Sahingoz2, Buket Gungor3, Fadime Aksoy4, Rustem Askin5. 1. Department of Psychiatry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. Electronic address: farukuguz@gmail.com. 2. Department of Psychiatry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. Electronic address: drpekalkan@hotmail.com. 3. Department of Psychiatry, Sevket Yilmaz Research and Training Hospital, Bursa, Turkey. Electronic address: buket.gungor@yahoo.com. 4. Department of Psychiatry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. Electronic address: fadime_aksoy84@hotmail.com. 5. Department of Psychiatry, Sevket Yilmaz Research and Training Hospital, Bursa, Turkey. Electronic address: rustemaskin@gmail.com.
Abstract
OBJECTIVE: The aim of the present study was to examine weight gain and its association with clinical and sociodemographic characteristics in patients using newer antidepressants. METHODS: The study had a cross-sectional design. A total of 362 consecutive psychiatric patients taking antidepressant drugs for 6 to 36 months were included in the study. RESULTS: The prevalence rate of weight gain was 55.2%; 40.6% of the patients had a weight gain of 7% or more compared to the baseline. Overall, antidepressant use was significantly related to increased body weight. Specifically, citalopram, escitalopram, sertraline, paroxetine, venlafaxine, duloxetine and mirtazapine, but not fluoxetine, were associated with significant weight gain. Multivariate logistic regression analysis indicated that lower education status, lower body mass index at the onset of antidepressant use and family history of obesity were independent predictors of weight gain ≥7% compared to the baseline. CONCLUSIONS: The study results suggest that patients who take newer antidepressants might have significant problems related to body weight.
OBJECTIVE: The aim of the present study was to examine weight gain and its association with clinical and sociodemographic characteristics in patients using newer antidepressants. METHODS: The study had a cross-sectional design. A total of 362 consecutive psychiatricpatients taking antidepressant drugs for 6 to 36 months were included in the study. RESULTS: The prevalence rate of weight gain was 55.2%; 40.6% of the patients had a weight gain of 7% or more compared to the baseline. Overall, antidepressant use was significantly related to increased body weight. Specifically, citalopram, escitalopram, sertraline, paroxetine, venlafaxine, duloxetine and mirtazapine, but not fluoxetine, were associated with significant weight gain. Multivariate logistic regression analysis indicated that lower education status, lower body mass index at the onset of antidepressant use and family history of obesity were independent predictors of weight gain ≥7% compared to the baseline. CONCLUSIONS: The study results suggest that patients who take newer antidepressants might have significant problems related to body weight.
Authors: Laura B Ramsey; Stacey L Aldrich; Ethan Poweleit; Cynthia A Prows; Lisa J Martin; Jeffrey R Strawn Journal: J Child Adolesc Psychopharmacol Date: 2018-11-14 Impact factor: 2.576
Authors: Csilla Terézia Nagy; Gábor Koncsos; Zoltán V Varga; Tamás Baranyai; Sebestyén Tuza; Ferenc Kassai; Aliz Judit Ernyey; István Gyertyán; Kornél Király; Attila Oláh; Tamás Radovits; Béla Merkely; Nóra Bukosza; Gábor Szénási; Péter Hamar; Domokos Mathé; Krisztián Szigeti; Csilla Pelyhe; Marek Jelemenský; Zsófia Onódi; Zsuzsanna Helyes; Rainer Schulz; Zoltán Giricz; Péter Ferdinandy Journal: Br J Pharmacol Date: 2018-08-07 Impact factor: 8.739
Authors: Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed Journal: Stem Cells Int Date: 2020-08-11 Impact factor: 5.443
Authors: Jess G Fiedorowicz; Lisa Brown; James Li; Sagar V Parikh; Boadie W Dunlop; Brent P Forester; Richard C Shelton; Michael E Thase; Matthew Macaluso; Kunbo Yu; John F Greden Journal: Psychopharmacol Bull Date: 2021-11-03
Authors: Katrine K Fjukstad; Lavinia Athanasiu; Shahram Bahrami; Kevin S O'Connell; Dennis van der Meer; Francesco Bettella; Ingrid Dieset; Nils Eiel Steen; Srdjan Djurovic; Olav Spigset; Ole A Andreassen Journal: Pharmacogenomics J Date: 2021-04-06 Impact factor: 3.550
Authors: Fatima Cody Stanford; Hellas Cena; Ginevra Biino; Olivia Umoren; Monik Jimenez; Marlene P Freeman; Aladdin H Shadyab; Robert A Wild; Catherine R Womack; Hailey R Banack; JoAnn E Manson Journal: Menopause Date: 2020-10 Impact factor: 3.310
Authors: Christian Ulrich von Linstow; Jonas Waider; Manuela Grebing; Athanasios Metaxas; Klaus Peter Lesch; Bente Finsen Journal: Alzheimers Res Ther Date: 2017-09-12 Impact factor: 6.982